DUDaniil Sergeevich Ulbashev

Daniil Sergeevich Ulbashev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniil Sergeevich Ulbashev has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of methods of thermal ablation and endovenous laser coagulation of lower extremity varicose veins in experiment: energy and temperature characteristics of impact on vein and surrounding tissues, effectiveness and safety

    by Dilshot M. Mamadaliyev, Gleb G. Borshchev, Daniil S. Ulbashev, Ruslan A. Sabanaev, Alika A. Makhonina, Eugene S. Ermolaev

    BACKGROUND: Lower extremity varicose vein disease is a common condition among people of working age, leading to serious complications and impairment of quality of life. Modern minimally invasive techniques, such as endovenous laser coagulation (EVLC) and radiofrequency ablation, are effective and safe; however, complications such as thrombosis, heat-induced lesions, recanalization and recurrence are possible. Steam thermal ablation (STA) is a promising technique that minimizes the risk of tissue damage via the use of the energy of condensing steam. AIM: To evaluate comparative characteristics of EVLC and STA in vitro: energy and temperature characteristics of impact on the vein and surrounding tissues, effectiveness and safety. METHODS: Experimental studies were performed on 38 veins removed during phlebectomy. The veins were randomly divided into groups depending on the obliteration method: STA in different modes and EVLC. An Acrovein steam-generating prototype complex (Russia) and a Lakhta Milon diode laser (Russia) were used. A system with continuous liquid circulation was used to simulate physiological conditions. Temperature distribution was modeled in MATLAB R2017b (Mathworks, USA). The technical characteristics of the catheters, including the minimum bending radius, were compared; after the procedure, a histological examination of the veins was performed to assess morphological changes. RESULTS: The maximum catheter temperature during EVLC (1470 nm) was 58 [48–69]°C, during STA in 1 pulse/cm mode — 36 [32–40]°C, STA in 3 pulse/cm mode — 44 [34–54]°C (p 0.05). During STA, after 4 pulses, the temperature reached a maximum of 58 [49–67]°C, further temperature increase was insignificant (p 0.05). The catheter for STA (Acrovein, Russia) withstood a bend of 0.5 mm in diameter, maintaining functionality, whereas the light guide for EVLC (Lakhta-Milon, Russia) fragmented at a radius of 3.0 mm. Modeling confirmed the safety of STA. During EVLC, vein perforation was noted in 57.1% of cases (n = 4; p 0.05), while during STA no perforations occurred. CONCLUSION: The results of the experimental study demonstrated the effectiveness of STA of varicose veins in vitro with a lower incidence of vessel perforation cases compared to EVLC.

  • Experimental evaluation of the effectiveness of the developed venous port system

    by D.M. Mamadaliev, E.S. Ermolaev, O.V. Khalepo, G.G. Borshchev, D.S. Ulbashev, P.A. Tilikin

  • Open Access

    Immediate and long-term outcomes of repeated endovascular correction of bifurcation lesions of coronary arteries

    by Yuri L. Shevchenko, Dmitry Yu. Ermakov, Dmitry I. Marchak, Daniil S. Ulbashev, Shamil A. Chotchaev, Mikhail A. Maslennikov, Alexander V. Baranov, Anastasia Yu. Vakhrameeva, Вахрамеева Анастасия Юрьевна

    INTRODUCTION: One of the main factors limiting the effectiveness of percutaneous coronary intervention (PCI) in the long-term follow-up period is in-stent restenosis (ISR). One predictor of its development is the initial bifurcation lesion (BL) of the coronary arteries (CA). Such patients present a particularly complicated group for endovascular treatment. AIM: To compare the results of different treatment methods for patients with coronary heart disease and ISR in the area of CA bifurcation. MATERIALS AND METHODS: A single-center, non-randomized, retrospective study included 105 patients with coronary heart disease with ISR in the area of CA bifurcation, who underwent PCI from 2012 to 2023. Group 1 (n = 40) included patients who underwent repeat revascularization using a one-stent coronary stenting technique, group 2 (n = 32) included patients who underwent revascularization using a two-stent technique, group 3 (n = 33) included patients in whom a non-stent treatment technology was used — application of an antiproliferative drug using drug-eluting balloon catheters. The median follow-up period was 380 [264; 411] days. RESULTS: There were no statistically significant differences in the ISR recurrence rate in all groups, however, there was a tendency for it to increase in groups 2 and 3: 8 (25.0%) in group 2 and 8 (24.2%) in group 3 versus 4 (10.0%) in group 1, p = 0.18. The frequency of myocardial infarction did not differ significantly in patients of the analyzed groups: 2 (5.0%) in group 1, 2 (6.3%) in group 2 and 1 (3.0%) in group 3, p = 0,828. There were also no differences in the proportion of adverse cardiovascular vents between the groups: 6 (15.0%) in group 1, 11 (34.3%) in group 2, and 9 (27.3%) in group 3, p = 0.154. When using a one-stent coronary stenting technique, there was a tendency to reduction of the number of adverse cardiovascular events in the late postoperative period compared to other methods, but it did not reach a statistically significant level: 6 (15.0%) versus 20 (30.7%), p = 0.07. CONCLUSION: Endovascular revascularization in binary ISR of the CA bifurcation zone using a one-stent, two-stent techniques and drug-eluting balloon catheters ensures satisfactory immediate and long-term outcomes with no statistical difference.

  • Open Access

    ENDOVASCULAR REVASCULARIZATION OF THE HEART IN COMBINATION WITH STIMULATION OF EXTRACARDIAL NEOANGIOGENESIS (YURLEON TECHNIQUE) DIFFUSE CORONARY ATHEROSCLEROSIS

    by Yu. L. Shevchenko, A. A. Katkov, D. S. Ulbashev, D. Yu. Ermakov

    In modern cardiac surgery practice, there is a significant increase in the number of patients with diffuse multivessel coronary artery disease, which is due to a combination of factors, including the widespread introduction of endovascular revascularization methods, prolonged drug therapy and the expansion of surgical indications. To optimize the treatment of this category of patients, in 2007, Academician Yu.L. Shevchenko proposed an innovative method for stimulating extracardial neoangiogenesis (“YurLeon”), which has received widespread clinical application.Aim. To evaluate the clinical efficacy of hybrid myocardial revascularization using the «YurLeon» and percutaneous coronary intervention in patients with coronary artery disease with diffuse coronary artery disease.Materials and methods. The study included 77 patients with diffuse coronary artery disease who were treated at the St. George Thoracic and Cardiovascular Surgery Clinic at the N.I. Pirogov National Medical and Surgical Center. 64.9% of them were men (n = 50), the median age was 72.00 years (68.00–75.00). Group I (n = 37) – patients who underwent hybrid revascularization (PCI+YurLeon); group II (n = 40) – control (isolated PCI). Clinical data, EchoCG, gated-SPECT, coronary angiography, and quality of life assessment (SAQ-7 questionnaire) were evaluated.Results. The results of a 12-month follow-up demonstrated a significant improvement in the left ventricular ejection fraction from 49% to 58% (pConclusion. The results of the study confirm the prospects of hybrid myocardial revascularization (PCI+YurLeon) in the treatment of patients with diffuse coronary artery disease, while the developed algorithms for patient selection and stratification according to expected effectiveness make it possible to optimize the use of this technique in clinical practice.

  • Open Access

    THE DIAGNOSIS OF VIABLE MYOCARDIUM BEFORE SURGERY AND ASSESSMENT OF THE DYNAMICS OF ITS RECOVERY AFTER CARDIAC REVASCULARIZATION

    by Yu. L. Shevchenko, A. Yu. Vakhrameeva, M. N. Vakhrameeva, D. S. Ulbashev

    The continuing high rates of morbidity, hospitalization and mortality of the population with coronary heart disease, despite the search for new diagnostic and treatment methods, indicate the urgency of the problem to date. Patients with coronary heart disease require an individual comprehensive approach due to the nature and severity of atherosclerotic lesions, the presence of a potentially viable myocardium, and the volume and severity of its hibernation. The introduction of the method of stimulation of extracardial neoangiogenesis into clinical practice has significantly expanded the treatment options for patients with diffuse coronary artery disease. The article presents data on preoperative visualization of a viable myocardium in patients with severe atherosclerotic lesions of the coronary bed, as well as the dynamics of its recovery in the postoperative period, depending on the performed surgical revascularization method.Materials and methods. The prospective, randomized study included data from 140 patients with coronary artery disease and diffuse coronary artery disease who underwent myocardial revascularization from 2016 to 2023 at the Department of Cardiovascular Surgery at the Moscow Institute of Thoracic and Cardiovascular Surgery. St. George’s Federal State Budgetary Institution “National Medical and Surgical Center named after N.I. Pirogov” of the Ministry of Health of the Russian Federation. Group I (n = 71) – complex revascularization; group II (n = 69) – isolated coronary bypass surgery. The results of gated-SPECT of the myocardium and echocardiography were evaluated early (10-14 days) and 6-12 months after surgery. Segmental analysis of changes in myocardial perfusion and contractility was performed. The main variants of perfusion-functional compliance were evaluated. The primary endpoint is a change in the volume of the hibernated myocardium during the entire follow-up period. Secondary endpoints are the dynamics of regional perfusion and contractility; changes in the left ventricular ejection fraction.Results. The volume of the hibernated left ventricular myocardium in the early postoperative period decreased from 29[20;35]% to 17[10;25]% in group I (p<0.0001) and from 27[20;34]% to 18[10;26]% in group II (p<0.0001). In the long-term postoperative period (6-12 months), the volume of viable myocardium was 10[5;12]% (group I) and 21[14;25]% (group II) (p = 0.0002). Three degrees of hibernation were distinguished depending on the dynamics of contractility recovery: mild (complete restoration of the “sleeping” myocardium in the early postoperative period, moderate (complete recovery within 6-12 months), severe (partial improvement of contractility within 12 months). After 12 months, the left ventricular ejection fraction was 56[54;59]% (group I) and 53[51;57]% (group II) (p<0.0001).Conclusion. The assessment of myocardial viability is an important criterion for choosing treatment tactics for patients with coronary artery disease, especially those with diffuse coronary artery disease. The addition of coronary bypass surgery to stimulate extracardial neoangiogenesis makes it possible to increase the restoration of the function of a larger volume of the hibernated myocardium and significantly improve the long-term results of complex treatment of patients.


  • Open Access

    Myocardial revascularization in the patients with coronary heart disease and oncological diseases

    by Sh.A. Chotchaev, A.а. Troshina, D.YU. Ermakov, D.S. Ulbashev, A.V. Baranov, I.A. Kopytin

    Реваскуляризация миокарда у пациентов с ишемической болезнью сердца и онкологическими заболеваниями

  • Open Access

    Long-term Outcomes of Coronary Artery Bypass Grafting and Staged Hybrid Myocardial Revascularization in Patients With Ischemic Heart Disease

    by Yury Leonidovich Shevchenko, Dmitry Yuryevich Ermakov, Gleb Gennadievich Borshchev, Anastasia Yuryevna Vakhrameeva, Daniil Sergeevich Ulbashev

    Introduction: Ischemic Heart Disease (IHD) remains a critical health concern both in Russia and globally. Surgical interventions, such as Coronary Artery Bypass Grafting (CABG) and coronary stenting, are commonly used to address IHD. However, in certain cases, single-stage complete revascularization may not be feasible. Hybrid Coronary Revascularization (HCR), a technique combining CABG with subsequent endovascular interventions, offers a potential solution to this challenge. Purpose: This study aims to compare the efficacy and safety of surgical myocardial revascularization using CABG vs. staged HCR. Materials and Methods: This retrospective, single-center, cohort, non-randomized study included 95 patients with IHD who underwent myocardial revascularization at the Pirogov National Medical and Surgical Center between 2017 and 2021. Group I (n=45) consisted of patients who received complete myocardial revascularization through CABG. Group II (n=50) comprised patients who underwent Hybrid Myocardial Revascularization (HMR), with CABG followed by Percutaneous Coronary Intervention (PCI). The median interval between CABG and PCI in Group II was 32.1±15.7 days. Results: Intraoperatively, the total procedure duration significantly differed between the groups, with Group I (CABG) having a mean duration of 242.8±45.9 min compared with 310±55.8 min in Group II (HMR) Pvs. 10 cases [16.1%], P=0.023) over the 24-month follow-up. Early and long-term postoperative mortality rates were similar between the groups, with no statistically significant differences. Conclusion: The efficacy and safety of standard CABG with extensive myocardial revascularization possible and the staged hybrid approach are comparable in the surgical treatment of patients with diffuse Coronary Artery Disease (CAD).


  • Open Access

    Comparative Results of Standard Coronary Artery Bypass Grafting, Staged Hybrid Myocardial Revascularization and Purely Endovascular Correction in Patients with Coronary Artery Disease in Long-Term Period after Surgery

    by Yuri L. Shevchenko, Gleb G. Borshchev, Dmitry Yu. Ermakov, Mikhail A. Maslennikov, Anastasia Yu. Vakhrameeva, Daniil S. Ulbashev, Вахрамеева Анастасия Юрьевна

    INTRODUCTION: Coronary artery disease (CAD) currently remains the leading cause of morbidity and mortality in Russia and in the world. In 2022, the overall morbidity with CAD among the adult population of Russia was 6517.9 per 100 thousand populations. The main surgical methods of treatment for CAD are coronary artery bypass grafting (CABG) and stenting of the coronary arteries. In some cases, a single-step complete revascularization is not possible, and one of solutions is a hybrid approach. AIM: To compare 5-year results of CABG, staged hybrid myocardial revascularization and isolated endovascular intervention in patients with CAD and multi-vessel lesion of the coronary arteries. MATERIALS AND METHODS: The prospective study included 330 patients with CAD and multi-vessel atherosclerotic lesion of the coronary arteries, who underwent planned myocardial revascularization in 2010–2018. Group 1 included 110 patients who underwent CABG, group 2 — 110 patients who underwent staged hybrid myocardial revascularization, group 3 included 110 patients after percutaneous coronary intervention. In 5-year follow-up period, clinical and instrumental data were evaluated, complications, lethal outcomes and re-interventions were considered. RESULTS: In the immediate period after the surgical intervention, frequency of cardiovascular complications and residual myocardial ischemia was expectedly low in all the groups (р 0.05). At 1 year of follow-up, cardiovascular complications were less common in group 2 (17.3%) compared to group 1 (29.1%, p = 0.038), while in group 3, adverse events were also noted in 27.3% of cases, however, the differences were not significant (p = 0.075). At 5 years, the frequency of cardiovascular complications prevailed in patients of group 1 (80.0%) compared to group 2 (57.3%) and group 3 (67.3%, p = 0.001–0.032). At the end of follow-up, the frequency of repeat revascularization was significantly higher in group 1 (41.8%) compared to group 2 (29.1%, p = 0.049). The number of such cases in group 3 (33.6%) was less than in group 1, however, the differences were not statistically significant (p = 0.125). CONCLUSION: Isolated CABG demonstrates a higher frequency of repeat endovascular interventions at 5 years after surgery compared to hybrid revascularization that also provides better results in terms of preventing cardiovascular complications.


  • Endovascular correction of lesions of coronary arteries and coronary artery bypass grafts in patients with coronary artery disease with recurrent ischemia after surgical myocardial revascularization

    by G.G. Borshchev, D.YU. Ermakov, A.YU. Vakhrameeva, D.S. Ulbashev

    Despite the modern optimal drug therapy and various surgical methods, coronary artery disease is currently one of the most significant problems of medicine. The risk of recurrent myocardial ischemia increases in long-term period after coronary artery bypass surgery, especially in patients with diffuse coronary lesions. The main factors of such results are progression of atherosclerosis and dysfunction of coronary artery grafts. Repeated myocardial revascularization through percutaneous coronary intervention is the safest and optimal option. However, there is currently no unambiguous and generally accepted opinion about endovascular treatment of such patients with diffuse coronary lesions. Objective. To estimate the efficacy and safety of endovascular correction of coronary artery and bypass graft lesions in patients with coronary artery disease, diffuse coronary artery lesions and myocardial ischemia recurrence after coronary artery bypass surgery. Material and methods. The study included 106 patients with recurrent myocardial ischemia after coronary artery bypass surgery who underwent treatment in 2013—2020. Coronary artery stenting was performed in the 1st group (55 (51.9%) patients), and graft stenting was carried out in the 2nd group (51 (48.1%) patients). Clinical and angiographic characteristics were similar. The endpoints were mortality, restenosis after endovascular correction, myocardial infarction and MACE after 1 and 12 months. Results. In the 1st group, lesion length and number of implanted stents were significantly greater: 25.7 [20.9; 31.6] and 18.8 [17.2; 22.1] mm p=0.023; 121 and 71 stents, respectively. Transradial access was more common in the 1st group (24 (43.6%) and 9 (17.6%), respectively, p=0.004). In long–term period, mortality and restenosis rate were slightly higher in the 2nd group (4 (7.3%) and 6 (11.8%) deaths, p=0.434; 7 (10.8%) and 9 (16.7%) cases of restenosis, respectively, p=0.352). The MACE rate was similar (11 (20.0%) and 15 (29.4%) cases, respectively, p=0.265). Conclusion. Stenting of native coronary arteries in patients with coronary artery disease, diffuse coronary lesions and recurrent myocardial ischemia after coronary artery bypass surgery demonstrates a tendency to better results within 1 and 12 months regarding restenosis, myocardial infarction rate and mortality compared to stenting of coronary artery bypass grafts.

  • Open Access

    Tactics of Endovascular Treatment of Patients with Coronary Heart Disease with Recurrent Coronary In-Stent Restenosis Using Second- and Third-Generation Stent Systems and Paclitaxel-Coated Balloon Catheters

    by Yuriy L. Shevchenko, Dmitriy Yu. Ermakov, Mikhail A. Maslennikov, Daniil S. Ul'BAshev, Anastasiya Yu. Vakhrameyeva, Вахрамеева Анастасия Юрьевна

    INTRODUCTION: The binary in-stent restenosis (ISR) still remains the main factor limiting the effectiveness of percutaneous coronary intervention in the long-term period. Histologically, ISR is defined as neointimal hyperplasia leading to hemodynamically significant narrowing of the arterial lumen. Patients with coronary artery (CA) restenosis represent a particularly challenging group for endovascular treatment. AIM: To compare effectiveness and safety of the endovascular correction of coronary in-stent restenosis using second- and third-generation stent systems and balloon angioplasty with a drug-coated balloon catheter. MATERIALS AND METHODS: The study retrospectively included 62 patients with recurrent ISR after the previous endovascular correction. The patients underwent treatment with re-stenting in Saint George Clinic of Thoracic and Cardiovascular Surgery of the National Pirogov Medical Surgical Center in 2016–2023 with use of second- and third-generation drug-eluting stents — cobalt (cobalt alloy) systems with zotarolimus, cobalt-chromium stent systems with sirolimus and zotarolimus, platinum-chromium stent systems with everolimus with biodegradable drug coating. Balloon angioplasty was performed using paclitaxel-coated balloon catheters. The primary endpoint of the study was the target lesion failure (TLF) of CA. The secondary endpoint was major adverse cardiovascular events (MACE). RESULTS: The TLF rate was 15.6% vs. 13.3% and 28.1% vs. 46.7% in the groups with use of a drug-eluting stent and balloon angioplasty at 1- and 2-year follow-up, respectively (p = 0.30). MACE was recorded in 18.8% vs. 16.7% and 37.5% vs. 56.7% of cases in the groups with use of a drug-eluting stent and balloon angioplasty at 1- and 2-year follow-up, respectively (p = 0.25). The dispersion analysis of predictors of TFL risks identified three factors showing a reliable correlation with the probability for TFL by the second follow-up year in both groups: (1) recurrence of binary ISR (hazard ratio (HR) 2.21; 95% confidence interval (CI) 0.95–4.01; p = 0.03)) in 365 days after the third stage of the percutaneous coronary intervention; (2) length of coronary restenotic lesion (per every 10 mm) (HR 1.25; 95% CI 0.99–1.40; p = 0.002); (3) occlusive restenosis (HR 4.16; 95% CI 0.43–26.96; p = 0.04). CONCLUSIONS: The implantation of a second- and third-generation drug-eluting stent and balloon angioplasty with use of a drug-coated catheter are comparable in the effectiveness and safety in correcting the recurrent ISR, however, restenting is associated with a lower probability for developing TFL and adverse events.